This Device Evaluation webcast is being made available to the general public. Contact us to learn about everything ECRI can do for your organization.
This webcast was held on March 20, 2024. A recording of the event appears below.
Overview
An estimated 8% of injuries to healthcare workers in the hospital setting and 17% of worker injuries in the surgical setting are associated with scalpels. Scalpel-related injuries occur most commonly when blades are being attached to or removed from the scalpel handle.
In our March 20, 2024, webcast, presenters discussed scalpel blade removers—devices designed to facilitate safe blade removal and exchange in a variety of settings. We recently evaluated 11 blade removers.
Watch as our experts discuss the prevalence of scalpel-related injuries, currently marketed scalpel blade removers and ECRI's testing methodology, and keys to successful implementation of the technology. Plus, listen in on the live Q&A.
Presenters
-
Julie Miller, MS, Principal Project Engineer 1, Device Evaluation, ECRI
-
Heather David, MSN, CRNP, Patient Safety Analyst, ECRI
-
Ron Stoker, Executive Director, International Sharps Injury Prevention Society
-
Rob Schluth, Principal Project Officer 1, Device Evaluation, ECRI
View a recording from the March 20, 2024, live-streamed lab webcast covering scalpel blade removers.
Length: 0:00.
Play
Image reproduced with permission from the International Sharps Injury Prevention Society.
|
ECRI Member Resource
Evaluation Background: Scalpel Blade Removers: Supporting information for our Evaluations of scalpel blade removers, including a summary of our product ratings and a rundown of how the technology is used, what factors we test for, and more.
Free Resource (no log-in required)
Scalpel Blade Removers: Technology Background: This article is a free, publicly accessible excerpt from ECRI's "Evaluation Background: Scalpel Blade Removers." It provides supporting information for ECRI's Evaluations of scalpel blade removers, including how the technology is used, what factors we test for, and typical costs.